State-of-the-Art in Invasive Vascular Interventions

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Vascular Medicine".

Deadline for manuscript submissions: closed (20 February 2024) | Viewed by 3736

Special Issue Editors

Heart and Vascular Center, Semmelweis University, Városmajor Str. 68, 1122 Budapest, Hungary
Interests: endovascular therapy; carotid stenting; lower extremity interventions; restenosis predictors; venous interventions
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Unit Vascular Surgery, University Hospital and Trust of Verona, Verona, Italy
Interests: aortic aneurysm; carotid disease; peripheral disease; venous pathology

Special Issue Information

Dear Colleagues,

Endovascular techniques can now be used in practically any location on the body (from the top of the head to the little toe). Some endovascular therapies are specifically designed to treat arterial disease, while others are specifically designed to treat venous disease. In the case of vascular procedures, percutaneous transluminal angioplasty (PTA) and stenting are the two most commonly performed methods. However, to date, there are still some disease types, such as chronic pulmonary hypertension, where long-term results of PTA are yet to be seen. Yet new devices have been developed in recent years. One such device is the Shockwave, which is specifically designed to treat calcified stenoses/occlusions. However, like many other new devices, we need more conclusive results on the outcomes of interventions that utilize Shockwave. In this Special Issue, we welcome authors to submit papers on the clinical relevance and short- and long-term outcomes of rarely performed invasive vascular therapies.

Dr. Edit Dósa
Dr. Luca Mezzetto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery interventions
  • non-coronary artery cardiac interventions
  • open surgical cardiac procedures
  • endovascular interventions
  • open surgical vascular procedures

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

11 pages, 2032 KiB  
Article
Fluoroscopy- and Endoscopy-Guided Transoral Sclerotherapy Using Foamed Polidocanol for Oropharyngolaryngeal Venous Malformations in a Hybrid Operation Room: A Case Series
by Kosuke Ishikawa, Taku Maeda, Emi Funayama, Naoki Murao, Takahiro Miura, Yuki Sasaki, Dongkyung Seo, Shintaro Mitamura, Shunichi Oide, Yuhei Yamamoto and Satoru Sasaki
J. Clin. Med. 2024, 13(8), 2369; https://doi.org/10.3390/jcm13082369 - 18 Apr 2024
Viewed by 274
Abstract
Background: Treatment of oropharyngolaryngeal venous malformations (VMs) remains challenging. This study evaluated the effectiveness and safety of fluoroscopy- and endoscopy-guided transoral sclerotherapy for oropharyngolaryngeal VMs in a hybrid operation room (OR). Methods: Patients with oropharyngolaryngeal VMs who underwent transoral sclerotherapy in a hybrid [...] Read more.
Background: Treatment of oropharyngolaryngeal venous malformations (VMs) remains challenging. This study evaluated the effectiveness and safety of fluoroscopy- and endoscopy-guided transoral sclerotherapy for oropharyngolaryngeal VMs in a hybrid operation room (OR). Methods: Patients with oropharyngolaryngeal VMs who underwent transoral sclerotherapy in a hybrid OR were enrolled. Results: Fourteen patients (six females, eight males; median age of 26 years; range, 4–71 years) were analyzed. The symptoms observed were breathing difficulties (n = 3), snoring (n = 2), sleep apnea (n = 1), and swallowing difficulties (n = 1). Lesions were extensive in the face and neck (n = 9) and limited in the oropharyngolarynx (n = 5). A permanent tracheostomy was performed on two patients, while a temporary tracheostomy was performed on five patients. The treated regions were the soft palate (n = 8), pharynx (n = 7), base of the tongue (n = 4), and epiglottis (n = 1). The median number of sclerotherapy sessions was 2.5 (range, 1–9). The median follow-up duration was 81 months (range, 6–141). Treatment outcomes were graded as excellent (n = 2), good (n = 7), or fair (n = 5). The post-treatment complication was bleeding (n = 1), resulting in an urgent tracheostomy. Conclusions: Fluoroscopy- and endoscopy-guided transoral sclerotherapy in a hybrid OR can be effective and safe for oropharyngolaryngeal VMs. Full article
(This article belongs to the Special Issue State-of-the-Art in Invasive Vascular Interventions)
Show Figures

Figure 1

10 pages, 1643 KiB  
Article
Combined Aspiration and Stent Retriever Thrombectomy for Distal Carotid Artery Occlusion Using Balloon Guide versus Non-Balloon Guide Catheter
by Ender Uysal, Bade von Bodelschwingh, Omer Naci Tabakci, Celal Ilker Basarir and Serpil Bulut
J. Clin. Med. 2024, 13(7), 1978; https://doi.org/10.3390/jcm13071978 - 29 Mar 2024
Viewed by 465
Abstract
Background: The introduction of endovascular thrombectomy dramatically changed acute stroke management and became the standard treatment. Balloon guide catheters provide flow arrest during the clot retrieval process and have several advantages.This study aimed to compare balloon guide catheters (BGCs) versus non-balloon guide [...] Read more.
Background: The introduction of endovascular thrombectomy dramatically changed acute stroke management and became the standard treatment. Balloon guide catheters provide flow arrest during the clot retrieval process and have several advantages.This study aimed to compare balloon guide catheters (BGCs) versus non-balloon guide catheters (NBGCs) as a part of a combined treatment modality in patients presenting with acute ischemic stroke. Methods: This retrospective study included n = 65 patients who underwent a combined endovascular stroke treatment for distal internal carotid artery (ICA) occlusion. Patients underwent aspiration and stent retriever thrombectomy with the use of BGCs (Group 1, n = 27) or NBGCs (Group 2, n = 38). Results: The groups were compared for outcomes: the National Institutes of Health Stroke Scale (NIHSSS) score change, successful recanalization, good functional outcome at three months, and in-hospital mortality. Conclusion: The two groups didn’t differ in terms of the NIHSS score change compared to baseline (p > 0.05). Moreover, there were no significant differences between the two groups in terms of the successful recanalization rate, three-month favorable functional outcome rate, and in-hospital mortality (p = 0.292, p = 0.952, p = 0.178), respectively. Further prospective studies with a larger number of patients and better methodology are warranted. Full article
(This article belongs to the Special Issue State-of-the-Art in Invasive Vascular Interventions)
Show Figures

Figure 1

Review

Jump to: Research

17 pages, 616 KiB  
Review
Advancements in Revascularization Strategies for Acute Mesenteric Ischemia: A Comprehensive Review
by Jacob J. Gries, Hafeez Ul Hassan Virk, Bing Chen, Takashi Sakamoto, Mahboob Alam and Chayakrit Krittanawong
J. Clin. Med. 2024, 13(2), 570; https://doi.org/10.3390/jcm13020570 - 19 Jan 2024
Viewed by 914
Abstract
Even with modern advancements in the management of acute mesenteric ischemia over the past decade, morbidity and mortality remain high, and the best primary treatment modality is still debated amongst interventionalists. Traditionally, interventionalists have favored an open surgical approach but are now trending [...] Read more.
Even with modern advancements in the management of acute mesenteric ischemia over the past decade, morbidity and mortality remain high, and the best primary treatment modality is still debated amongst interventionalists. Traditionally, interventionalists have favored an open surgical approach but are now trending for endovascular interventions due to apparent reduced mortality and complications. Newer studies suggest hybrid approaches, and intestinal stroke centers may be superior to either strategy alone. This narrative review will explore the natural history of acute mesenteric ischemia with the aim of increasing interventionalist awareness of modern advancements in revascularization strategies for this devastating disease. Full article
(This article belongs to the Special Issue State-of-the-Art in Invasive Vascular Interventions)
Show Figures

Figure 1

19 pages, 646 KiB  
Review
Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review
by Genti Xhepa, Andrea Vanzulli, Lucilla Violetta Sciacqua, Agostino Inzerillo, Pierre Faerber, Anna Maria Ierardi, Gianpaolo Carrafiello, Filippo Del Grande and Alexis Ricoeur
J. Clin. Med. 2023, 12(22), 7112; https://doi.org/10.3390/jcm12227112 - 15 Nov 2023
Viewed by 1719
Abstract
Chronic mesenteric ischemia (CMI) arises from the inability to achieve adequate intestinal blood flow after meals, leading to an imbalance between oxygen and metabolite supply and demand. The true incidence of CMI remains uncertain. However, the occurrence of mesenteric artery occlusive disease (MAOD) [...] Read more.
Chronic mesenteric ischemia (CMI) arises from the inability to achieve adequate intestinal blood flow after meals, leading to an imbalance between oxygen and metabolite supply and demand. The true incidence of CMI remains uncertain. However, the occurrence of mesenteric artery occlusive disease (MAOD) is relatively common among the elderly population. Delays in diagnosing CMI can often be attributed to several factors, including the variability in patient symptoms and the range of potential causes for chronic abdominal pain with weight loss. Mikkelson pioneered the introduction of a surgical treatment for occlusive lesions of the superior mesenteric artery (SMA) in 1957. The inaugural performance of endovascular revascularization (ER) for visceral vessels took place in 1980. The literature has documented two types of endovascular revascularization (ER) methods: percutaneous transluminal angioplasty (PTA) and primary stenting (PMAS). Despite the limited quality of available evidence, the consensus among experts is strongly in favor of PMAS over PTA alone for the treatment of atherosclerotic mesenteric artery stenosis. There are several key areas of focus for chronic mesenteric ischemia (CMI) treatment. Randomized controlled trials comparing different stent types, such as covered stents versus bare metal stents, are needed to evaluate efficacy, patency rates, and long-term outcomes in CMI patients. Full article
(This article belongs to the Special Issue State-of-the-Art in Invasive Vascular Interventions)
Show Figures

Graphical abstract

Back to TopTop